Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001493152-21-029297

CEO and Director bought 11,187 shares at $5.82 ($65,108)

From the SEC's structured data for this filing

Trades in this filing

Meckler Jeffrey A · CEO and Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-11-18 Purchase : show line 1 in the form +11,187 $5.82 $65,108 25,647 D
Open-market purchases · 11,187 sh · avg $5.82 · $65,108
Loading xslF345X03/ownership.xml…